Virus therapy shows promise in pancreatic cancer trial
Disease control
Completed
This study tested a modified virus called LOAd703 in 51 people with pancreatic cancer. The virus is designed to infect and kill cancer cells while also boosting the immune system. It was given alongside standard chemotherapy, with or without an immunotherapy drug, to see if it is…
Phase: PHASE1, PHASE2 • Sponsor: Lokon Pharma AB • Aim: Disease control
Last updated May 17, 2026 05:07 UTC